← Back to Screener
Cosmos Holdings Inc. Common Stock (COSM)
Price$0.41
Favorite Metrics
Price vs S&P 500 (26W)-67.15%
Price vs S&P 500 (4W)17.75%
Market Capitalization$14.62M
All Metrics
Book Value / Share (Quarterly)$0.73
P/TBV (Annual)0.93x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)-1.09%
Cash Flow / Share (Quarterly)$-0.31
Price vs S&P 500 (YTD)-24.23%
Gross Margin (TTM)11.41%
Net Profit Margin (TTM)-31.01%
EPS (TTM)$-0.71
10-Day Avg Trading Volume1.49M
EPS Excl Extra (TTM)$-0.71
Revenue Growth (5Y)6.52%
EPS (Annual)$-0.85
ROI (Annual)-45.38%
Gross Margin (Annual)7.92%
Net Profit Margin (5Y Avg)-20.92%
Cash / Share (Quarterly)$0.03
Revenue Growth QoQ (YoY)37.86%
ROA (Last FY)-29.80%
Revenue Growth TTM (YoY)6.69%
EBITD / Share (TTM)$-0.48
ROE (5Y Avg)-44.72%
Operating Margin (TTM)-23.86%
Cash Flow / Share (Annual)$-0.38
P/B Ratio0.63x
P/B Ratio (Quarterly)1.45x
Net Income / Employee (Annual)$-0
EV / Revenue (TTM)0.57x
Net Interest Coverage (TTM)-21.32x
ROA (TTM)-30.54%
EV / EBITDA (TTM)43.22x
EPS Incl Extra (Annual)$-0.85
Current Ratio (Annual)0.99x
Quick Ratio (Quarterly)0.68x
3-Month Avg Trading Volume0.83M
52-Week Price Return14.18%
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$0.48
P/S Ratio (Annual)0.27x
Asset Turnover (Annual)1.00x
52-Week High$1.32
Operating Margin (5Y Avg)-15.28%
EPS Excl Extra (Annual)$-0.85
CapEx CAGR (5Y)13.59%
26-Week Price Return-63.16%
Quick Ratio (Annual)0.63x
13-Week Price Return-22.46%
Total Debt / Equity (Annual)0.45x
Current Ratio (Quarterly)0.99x
Enterprise Value$34.147
Revenue / Share Growth (5Y)-48.02%
Asset Turnover (TTM)0.98x
Revenue / Employee (Annual)$0
Inventory Turnover (Annual)10.96x
Pretax Margin (Annual)-29.73%
Cash / Share (Annual)$0.01
3-Month Return Std Dev87.13%
Gross Margin (5Y Avg)11.45%
Net Income / Employee (TTM)$-0
ROE (Last FY)-65.96%
Net Interest Coverage (Annual)-3.25x
EPS Basic Excl Extra (Annual)$-0.85
P/FCF (TTM)28.60x
Receivables Turnover (TTM)3.11x
Total Debt / Equity (Quarterly)0.88x
EPS Incl Extra (TTM)$-0.71
Receivables Turnover (Annual)3.06x
ROI (TTM)-46.78%
P/S Ratio (TTM)0.24x
Pretax Margin (5Y Avg)-20.44%
Revenue / Share (Annual)$2.84
Tangible BV / Share (Annual)$0.71
Forward P/E5.08x
Price vs S&P 500 (52W)-15.65%
Year-to-Date Return-21.59%
5-Day Price Return34.66%
EPS Normalized (Annual)$-0.85
ROA (5Y Avg)-18.49%
Net Profit Margin (Annual)-29.73%
Month-to-Date Return23.11%
Cash Flow / Share (TTM)$-1.56
EBITD / Share (Annual)$-0.74
Operating Margin (Annual)-28.56%
LT Debt / Equity (Annual)0.06x
ROI (5Y Avg)-7.30%
LT Debt / Equity (Quarterly)0.25x
EPS Basic Excl Extra (TTM)$-0.71
P/TBV (Quarterly)2.21x
P/B Ratio (Annual)0.63x
Inventory Turnover (TTM)10.02x
Pretax Margin (TTM)-31.01%
Book Value / Share (Annual)$1.04
Price vs S&P 500 (13W)-23.15%
Beta4.57x
P/FCF (Annual)2.25x
Revenue / Share (TTM)$1.95
ROE (TTM)-74.28%
52-Week Low$0.28
Analyst Recommendations
Feb 2025
Mar 2025
Apr 2025
May 2025
4.14
4.14
4.14
4.14
Industry Peers — Drug Wholesale(8)
| Symbol | P/E Ratio (Annual) | ROE (TTM) | Operating Margin (TTM) | Revenue Growth TTM (YoY) | Price |
|---|---|---|---|---|---|
COSMCosmos Holdings Inc. Common Stock | — | -74.28% | -23.86% | 6.69% | $0.41 |
MCKMcKesson Corporation | 32.34x | 39.43% | 1.42% | 15.49% | $867.34 |
CORCencora, Inc. | 40.35x | 101.43% | 0.82% | 7.45% | $322.37 |
CAHCardinal Health, Inc. | 32.10x | 37.17% | 1.04% | 10.13% | $213.10 |
HLFHerbalife Ltd. | 7.65x | 170.70% | -14.76% | 0.89% | $16.17 |
NUSNuSkin Enterprises, Inc. | 2.30x | 20.36% | 16.29% | -14.26% | $7.65 |
WGRXWellgistics Health, Inc. Common Stock | — | -1645.88% | -414.51% | 28.73% | $0.15 |
ZSTKZeroStack Corp. Common Stock | — | -332.01% | -339.14% | — | $6.91 |
HWHHWH International Inc. Common Stock | — | -88.53% | -326.05% | -30.84% | $1.17 |
About
Cosmos Health Inc manufactures and distributes branded and generic pharmaceuticals, over-the-counter medications, and proprietary nutraceutical brands (Sky Premium Life and Mediterranation) through wholesale distributors, wholesalers, and retail healthcare providers. The company operates across four primary segments—Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals, and Other—with the Wholesale segment generating the majority of revenue.